"ｍＲＮＡワクチン" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonmRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...
FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama - Ars Technica
FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Contin...
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing Memorial Sloan Kettering Cancer Center
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine The New England Journal of Medicine
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus CEPI
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - UT MD Anderson
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy UT MD Anderson
Pancreatic cancer mRNA vaccine shows lasting results in an early trial - NBC News
Pancreatic cancer mRNA vaccine shows lasting results in an early trial NBC News
Experimental mRNA flu vaccine shows superior efficacy against symptomatic illness - CIDRAP
Experimental mRNA flu vaccine shows superior efficacy against symptomatic illness CIDRAP
mRNA Vaccines and Therapeutics Market Size, Share, Growth, 2034 - Straits Research
mRNA Vaccines and Therapeutics Market Size, Share, Growth, 2034 Straits Research
Risks of Cuts to mRNA Vaccine Development - Johns Hopkins Bloomberg School of Public Health
Risks of Cuts to mRNA Vaccine Development Johns Hopkins Bloomberg School of Public Health
Senate Hearing Questions COVID Vaccine Safety - Legis1
Mitochondrial vulnerability underlies myocarditis from COVID-19 mRNA vaccine - Nature
Mitochondrial vulnerability underlies myocarditis from COVID-19 mRNA vaccine Nature
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo - Ars Technica
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo Ars Technica
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate CEPI
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents - Nature
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents Nature
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial - Nature
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Tuning the immune response to mRNA vaccines - Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
People with some cancers live longer after a COVID vaccine - Nature
People with some cancers live longer after a COVID vaccine Nature
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate - The Hill
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate The Hill
DNA origami vaccines could be the next leap beyond mRNA - ScienceDaily
DNA origami vaccines could be the next leap beyond mRNA ScienceDaily
What are the biggest vaccine breakthroughs coming in 2026? We asked five experts - Gavi, the Vacc...
What are the biggest vaccine breakthroughs coming in 2026? We asked five experts Gavi, the Vaccine Alliance
Personalized cancer vaccines are almost here—but federal funding cuts could derail them - Scienti...
Personalized cancer vaccines are almost here—but federal funding cuts could derail them Scientific American
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination - American ...
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination American Heart Association Journals
Study finds mRNA coronavirus vaccines prolonged life of cancer patients - The Washington Post
Study finds mRNA coronavirus vaccines prolonged life of cancer patients The Washington Post
COVID-19 mRNA Vaccines May Boost Immunotherapy, Doubling Survival in Aggressive Cancers - Inside ...
COVID-19 mRNA Vaccines May Boost Immunotherapy, Doubling Survival in Aggressive Cancers Inside Precision Medicine
Bayer sues COVID vaccine makers over mRNA technology - Reuters
Bayer sues COVID vaccine makers over mRNA technology Reuters
Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination - Gavi, t...
Massive four-year study finds no increase in deaths linked to COVID-19 mRNA vaccination Gavi, the Vaccine Alliance
Moderna wins EU approval for combined flu, COVID shot for older adults - Reuters
Moderna wins EU approval for combined flu, COVID shot for older adults Reuters
mRNA vaccines for HIV trigger strong immune response in people - Nature
mRNA vaccines for HIV trigger strong immune response in people Nature
RFK Jr. cancels at least $500M in mRNA vaccine funding. What are the implications? - ABC News - B...
RFK Jr. cancels at least $500M in mRNA vaccine funding. What are the implications? ABC News - Breaking News, Latest News and Videos
RFK Jr cancels $500m in mRNA vaccine development in the US - BBC
RFK Jr cancels $500m in mRNA vaccine development in the US BBC
Moderna's reshaping rolls on with 3 more pipeline purges - Fierce Biotech
Moderna's reshaping rolls on with 3 more pipeline purges Fierce Biotech
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine - GOV.UK
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine GOV.UK
Six companies leading the mRNA revolution in biotechnology - Labiotech.eu
Six companies leading the mRNA revolution in biotechnology Labiotech.eu
RFK Jr. pulls $500 million in funding for vaccine development - ABC7 Los Angeles
RFK Jr. pulls $500 million in funding for vaccine development ABC7 Los Angeles
BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions - Health Policy Watch
BioNTech Factory Closures Spark Concerns Over EU Supplies Amid Trade Tensions Health Policy Watch
Moderna Flu Breakthrough And Hantavirus Push Reframe Long Term Story - Yahoo Finance
Moderna Flu Breakthrough And Hantavirus Push Reframe Long Term Story Yahoo Finance
Vaccine Makers Curtail Research and Cut Jobs - The New York Times
Vaccine Makers Curtail Research and Cut Jobs The New York Times
KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks - BioWorld News
KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks BioWorld News
Respirology Case Reports | APSR Respiratory Medicine Journal - Wiley Online Library
Respirology Case Reports | APSR Respiratory Medicine Journal Wiley Online Library
Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels S...
Korea University and Moderna have been working on mRNA hantavirus vaccine since 2023 Brussels Signal
Tech boss uses ChatGPT to create cancer vaccine to save dying dog - The Australian
Tech boss uses ChatGPT to create cancer vaccine to save dying dog The Australian
Trump and RFK Jr. to Ban COVID-19 Vaccine ‘Within Months’ - The Daily Beast
Trump and RFK Jr. to Ban COVID-19 Vaccine ‘Within Months’ The Daily Beast
COVID-19 mRNA Vaccine Production - National Human Genome Research Institute (NHGRI) (.gov)
COVID-19 mRNA Vaccine Production National Human Genome Research Institute (NHGRI) (.gov)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - The New England Journal of Medicine
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine The New England Journal of Medicine
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants - ...
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants Nature
Comparing the COVID-19 Vaccines: How Are They Different? - Yale Medicine
Comparing the COVID-19 Vaccines: How Are They Different? Yale Medicine
FDA Updates CV Warnings Around COVID-19 mRNA Vaccines - TCTMD.com
FDA Updates CV Warnings Around COVID-19 mRNA Vaccines TCTMD.com
Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines - Na...
Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection | npj Vaccines Nature
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - The New England Journal of Medicine
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report The New England Journal of Medicine
Creating the Next Generation of mRNA Vaccines - Harvard Medical School
Creating the Next Generation of mRNA Vaccines Harvard Medical School
The Science Behind The Historic mRNA Vaccine : Short Wave - NPR
The Science Behind The Historic mRNA Vaccine : Short Wave NPR
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine The New England Journal of Medicine
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel - The New England Journal...
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel The New England Journal of Medicine
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting - The New England Journal of...
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting The New England Journal of Medicine
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons - The New England Journa...
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons The New England Journal of Medicine
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next - NPR
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next NPR
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults - The New England Journ...
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults The New England Journal of Medicine
Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine - N...
Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine Nature
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces th...
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement i...
What are mRNA vaccines and how do they work? - GOV.UK blogs
What are mRNA vaccines and how do they work? GOV.UK blogs
How mRNA Vaccines Might Help Treat Cancer - National Cancer Institute (.gov)
How mRNA Vaccines Might Help Treat Cancer National Cancer Institute (.gov)
Development of mRNA vaccine indicating therapeutic effect against gastric cancer with peritoneal ...
Moderna says mRNA flu vaccine sailed through trial, beating standard shot - Ars Technica
Moderna says mRNA flu vaccine sailed through trial, beating standard shot Ars Technica
mRNA vaccines for infectious diseases: principles, delivery and clinical translation - Nature
mRNA vaccines for infectious diseases: principles, delivery and clinical translation Nature
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled...
The tangled history of mRNA vaccines - Nature
mRNA COVID vaccines saved lives and won a Nobel — what’s next for the technology? - Nature
mRNA COVID vaccines saved lives and won a Nobel — what’s next for the technology? Nature
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors ...
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors Nature
NIH to ax grants on vaccine hesitancy - Science | AAAS
NIH to ax grants on vaccine hesitancy Science | AAAS
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Nature
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibo...
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster S...
RFK Jr. weighs adding critics of coronavirus shots to key vaccine panel - The Washington Post
RFK Jr. weighs adding critics of coronavirus shots to key vaccine panel The Washington Post
Next generation self-replicating RNA vectors for vaccines and immunotherapies | Cancer Gene Thera...
Next generation self-replicating RNA vectors for vaccines and immunotherapies | Cancer Gene Therapy Nature
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination - Science | AAAS
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination Science | AAAS
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health syste...
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines - The New England...
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines The New England Journal of Medicine
RNA vaccines: the way of the future? - American Animal Hospital Association - AAHA
RNA vaccines: the way of the future? American Animal Hospital Association - AAHA
Katalin Karikó and Drew Weissman were jointly awarded the Nobel Prize in Physiology or Medicine 2...
Katalin Karikó and Drew Weissman were jointly awarded the Nobel Prize in Physiology or Medicine 2023 World Health Organization (WHO)
Japan Approves Updated Self-Amplifying mRNA COVID-19 Vaccine - Contagion Live
Japan Approves Updated Self-Amplifying mRNA COVID-19 Vaccine Contagion Live
High coverage COVID-19 mRNA vaccination rapidly controls SARS-CoV-2 transmission in long-term car...
Impact of sex and age on vaccine-related side effects and their progression after booster mRNA CO...
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults - Nature
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Nature
Moderna/Merck begins late-stage study of skin cancer vaccine combination - Reuters
Moderna/Merck begins late-stage study of skin cancer vaccine combination Reuters
Adults Vaccines Market Size, Share | Growth Report [2034] - Fortune Business Insights
Adults Vaccines Market Size, Share | Growth Report [2034] Fortune Business Insights
Moderna and Korea University to co-develop hantavirus vaccine - koreabiomed.com
Moderna and Korea University to co-develop hantavirus vaccine koreabiomed.com
Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination dep...
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health - NBC News
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health NBC News
The U.S. Department of Health and Human Services has withdrawn funding for mRNA vaccine developme...
Hopes Are Rising for a Homegrown mRNA Vaccine in China - Bloomberg.com
Hopes Are Rising for a Homegrown mRNA Vaccine in China Bloomberg.com
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination p...
Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial - News-Medical
Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial News-Medical
Maintaining Safety with SARS-CoV-2 Vaccines - The New England Journal of Medicine
Maintaining Safety with SARS-CoV-2 Vaccines The New England Journal of Medicine
Africa’s first mRNA vaccine technology transfer hub gets to work - The Conversation
Africa’s first mRNA vaccine technology transfer hub gets to work The Conversation
Moderna's groundbreaking coronavirus vaccine was designed in just 2 days - Business Insider
Moderna's groundbreaking coronavirus vaccine was designed in just 2 days Business Insider
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity a...
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses Science | AAAS